SuperworthAIM ImmunoTech shares outstanding AIM
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 17.1M
- On a year earlier
- +2154.6%
- more shares
AIM ImmunoTech had 17.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2154.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 2.9M | +349% |
| FY2024 | 639.6K | +31% |
| FY2023 | 488.9K | +2% |
| FY2022 | 480.8K | +0% |
| FY2021 | 478.9K | +17% |
| FY2020 | 408.3K | +362% |
| FY2019 | 88.4K | +702% |
| FY2018 | 11K | +52% |
| FY2017 | 7.2K | +32% |
| FY2016 | 5.5K | +17% |
| FY2015 | 4.7K | +24% |
| FY2014 | 3.8K | +19% |
| FY2013 | 3.2K | +8% |
| FY2012 | 2.9K | +14% |
| FY2011 | 2.6K | +0% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 17.1M | +2155% | |
| Q1 FY26 | 4.4M | +519% | |
| Q4 FY25 | 2.9M | +349% | |
| Q3 FY25 | 2.1M | +263% | |
| Q2 FY25 | 759.3K | +44% | |
| Q1 FY25 | 703.3K | +42% | |
| Q4 FY24 | 639.6K | +31% | |
| Q3 FY24 | 576.8K | +19% | |
| Q2 FY24 | 528.4K | +9% | |
| Q1 FY24 | 494.6K | +2% | |
| Q4 FY23 | 488.9K | +2% | |
| Q3 FY23 | 486.4K | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on AIM ImmunoTech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.